ENL - Enaleni Pharmaceuticals Limited - Dealing In
ENL
ENL
ENL - Enaleni Pharmaceuticals Limited - Dealing In Securities By Directors
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni" or "the Company")
DEALING IN SECURITIES BY DIRECTORS
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements,
the following information relates to the sale of ordinary shares by a director
of Enaleni:
Executive director: P A Pillay
Number of shares: 400 000
Price per share: 400 cents per share
Value of transaction: R1 600 000
Nature of Transaction: Sale
Extent of interest: Direct beneficial
Date of transaction: 28 September 2007
Written clearance to
deal obtained: Yes
Johannesburg
01 October 2007
Sponsor
Nedbank Capital
Date: 01/10/2007 16:23:48 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.